4-Fluoro-2-(trifluoromethyl)benzaldehyde
Names
[ CAS No. ]:
90176-80-0
[ Name ]:
4-Fluoro-2-(trifluoromethyl)benzaldehyde
[Synonym ]:
4-fluoro-2-trifluoromethyl benzaldehyde
5-Fluoro-2-formylbenzotrifluoride
4-Fluoro-2-(trifluoromethyl)benzaldehyde
Benzaldehyde, 4-fluoro-2-(trifluoromethyl)-
α,α,α,4-Tetrafluoro-o-tolualdehyde
VHR DF BXFFF
MFCD00061313
Chemical & Physical Properties
[ Density]:
1.4±0.1 g/cm3
[ Boiling Point ]:
195.0±40.0 °C at 760 mmHg
[ Molecular Formula ]:
C8H4F4O
[ Molecular Weight ]:
192.110
[ Flash Point ]:
72.1±21.5 °C
[ Exact Mass ]:
192.019821
[ PSA ]:
17.07000
[ LogP ]:
2.32
[ Vapour Pressure ]:
0.4±0.4 mmHg at 25°C
[ Index of Refraction ]:
1.459
MSDS
Safety Information
[ Symbol ]:
GHS02, GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H226-H315-H319-H335
[ Precautionary Statements ]:
P261-P305 + P351 + P338
[ Personal Protective Equipment ]:
Eyeshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter
[ Hazard Codes ]:
Xi:Irritant;
[ Risk Phrases ]:
R36/37/38
[ Safety Phrases ]:
S26-S36-S37/39
[ RIDADR ]:
UN 1989 3/PG 3
[ WGK Germany ]:
3
[ Packaging Group ]:
III
[ Hazard Class ]:
3
[ HS Code ]:
2913000090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2913000090
[ Summary ]:
HS: 2913000090 halogenated, sulphonated, nitrated or nitrosated derivatives of products of heading 2912 Educational tariff:17.0% Tax rebate rate:9.0% Regulatory conditions:none Most favored nation tariff:5.5% General tariff:30.0%
Articles
Bioorg. Med. Chem. Lett. 19(5) , 1310-13, (2009)
The first examples of thioether-substituted benzonitriles as potential soft-drug androgen receptor antagonists are reported. A number of 4-(alkylthio)- and of 4-(arylthio)-benzonitrile analogs were ev...
Rational design and synthesis of androgen receptor-targeted nonsteroidal anti-androgen ligands for the tumor-specific delivery of a doxorubicin-formaldehyde conjugate.J. Med. Chem. 46(24) , 5258-70, (2003)
The synthesis and preliminary evaluation of a doxorubicin-formaldehyde conjugate tethered to the nonsteroidal antiandrogen, cyanonilutamide (RU 56279), for the treatment of prostate cancer are reporte...